Kei Morio

Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis

Yuko Nagaoki, Hiroshi Aikata, Kana Daijyo et al. · Hepatology Research · 2017 · 145 citations

Development of hepatocellular carcinoma in patients with hepatitis C virus infection who achieved sustained virological response following interferon therapy: A large‐scale, long‐term cohort study

Yuko Nagaoki, Hiroshi Aikata, Norihito Nakano et al. · Journal of Gastroenterology and Hepatology · 2015 · 60 citations

Levocarnitine Use Is Associated With Improvement in Sarcopenia in Patients With Liver Cirrhosis

Akira Hiramatsu, Hiroshi Aikata, Shinsuke Uchikawa et al. · Hepatology Communications · 2019 · 60 citations · Full text

Correlation between Early Tumor Marker Response and Imaging Response in Patients with Advanced Hepatocellular Carcinoma Treated with Lenvatinib

Kenichiro Kodama, Tomokazu Kawaoka, Maiko Namba et al. · Oncology · 2019 · 57 citations

The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy

Yuko Nagaoki, Michio Imamura, Hiroshi Aikata et al. · PLoS ONE · 2017 · 56 citations · Full text